Does Enzalutamide Really Reduce the Risk of Progression Compared With Bicalutamide in Patients With Castration-Resistant Prostate Cancer?

Does Enzalutamide Really Reduce the Risk of Progression Compared With Bicalutamide in Patients With Castration-Resistant Prostate Cancer? J Clin Oncol. 2017 Jan;35(1):122 Authors: Şendur MA, Yalçın B PMID: 28034074 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28034074?dopt=Abstract

Source: Clinical Prostate Cancer - December 31, 2016 Category: Cancer & Oncology Authors: Şendur MA, Yalçın B Tags: J Clin Oncol Source Type: research

More News: Cancer | Cancer & Oncology | Prostate Cancer